Literature DB >> 12842810

Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation.

Adviye Ergul1, Vera Portik-Dobos, Ararat D Giulumian, Mariela M Molero, Leslie C Fuchs.   

Abstract

Degradation of the extracellular matrix proteins by matrix metalloproteinases (MMP) is an important regulatory step in the vascular remodeling process. Recent studies demonstrated that ETA receptors regulate cardiac MMP activity and fibrosis in DOCA-salt hypertension. However, little is known about endothelin (ET)-1 regulation of vascular MMP activity in hypertension. Thus early changes in ET-1-mediated regulation of MMP activity were measured in borderline hypertensive rats that develop impaired vasorelaxation and hypertension with chronic exposure to stress. Experiments were performed after 10 days of exposure to the behavioral stressor, air-jet stress, but before the onset of stress-induced hypertension. Study groups were 1) control (n = 8); 2) air-jet stress for 10 days (n = 8); 3) control plus ETA antagonist ABT-627 (n = 4), and 4) air-jet stress plus ETA antagonist (n = 4). MMP activity in the thoracic aorta was assessed by gelatin zymography. MMP protein and tissue ET-1 levels were evaluated by immunohistochemistry, and ET receptor density was determined by immunoblotting. Exposure to stress caused a twofold increase in plasma ET-1 levels (P < 0.05), and there was increased ET-1 staining at the tissue level. Total MMP activity and expression of MMP-2 and MMP-9 were increased in the stress group. ETA receptor antagonism prevented the increase in MMP expression and activation in the stress group. These results provide evidence that the MMP system is activated before the development of hypertension and ET-1 mediates these early events in vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842810     DOI: 10.1152/ajpheart.00133.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions.

Authors:  Amie K Lund; JoAnn Lucero; Melissa Harman; Michael C Madden; Jacob D McDonald; Jean Clare Seagrave; Matthew J Campen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

Authors:  Kamakshi Sachidanandam; Vera Portik-Dobos; Aisha I Kelly-Cobbs; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

3.  Plasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension.

Authors:  M A Al-Omari; M Khaleghi; T H Mosley; N G Morgenthaler; J Struck; A Bergmann; I J Kullo
Journal:  J Hum Hypertens       Date:  2010-02-25       Impact factor: 3.012

Review 4.  An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage.

Authors:  Geert W Schmid-Schönbein
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

5.  Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.

Authors:  Alain F Tanbe; Raouf A Khalil
Journal:  Curr Bioact Compd       Date:  2010-03-01

6.  Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1.

Authors:  Martin Houde; Marc-David Jamain; Julie Labonté; Louisane Desbiens; Gunnar Pejler; Michael Gurish; Shinji Takai; Pedro D'Orléans-Juste
Journal:  J Pharmacol Exp Ther       Date:  2013-04-17       Impact factor: 4.030

7.  Inhaled diesel emissions alter atherosclerotic plaque composition in ApoE(-/-) mice.

Authors:  Matthew J Campen; Amie K Lund; Travis L Knuckles; Daniel J Conklin; Barbara Bishop; David Young; Steven Seilkop; JeanClare Seagrave; Matthew D Reed; Jacob D McDonald
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-03       Impact factor: 4.219

8.  Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways.

Authors:  Amie K Lund; JoAnn Lucero; Selitá Lucas; Michael C Madden; Jacob D McDonald; Jean-Clare Seagrave; Travis L Knuckles; Matthew J Campen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-15       Impact factor: 8.311

9.  Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.

Authors:  T Kobayashi; T Nogami; K Taguchi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

10.  Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients.

Authors:  Adviye Ergul; Dena Jupin; Maribeth H Johnson; L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.